R-Lipoic Acid (Natural / Stabilized R-ALA)

Evidence Level
Preliminary
2 Clinical Trials
5 Documented Benefits
1/5 Evidence Score

R-lipoic acid (R-ALA) is one of the two mirror-image forms of alpha-lipoic acid, and it is the form the body makes and uses inside its own cells. Standard ALA supplements are a 50/50 mixture of the R and S forms. R-ALA supplies only the R half, so labels use lower milligram amounts, but no cited study shows a bigger effect per milligram in people. Plain R-ALA is unstable, so it is usually sold as a stabilized form such as a sodium salt. Be clear about what this page can and cannot tell you: every study cited here is an absorption study in a small group of healthy volunteers that measured only how much lipoic acid reached the bloodstream. None measured symptoms, long-term blood sugar, or any other health outcome. The clinical research usually quoted for lipoic acid used the racemic form, so see our alpha-lipoic acid page for that evidence.

Studied Dose Products typically supply 100-300 mg/day of R-ALA. The cited studies gave only single absorption doses (600 mg sodium R-lipoate; 50 to 600 mg racemic thioctic acid), not a daily regimen.
Active Compound (R)-(+)-alpha-lipoic acid (R-ALA / R-LA)

Benefits

Diabetic Peripheral Neuropathy

None of the four studies cited on this page looked at nerve symptoms or any other health outcome. They measured blood levels only. The human trials in people with diabetic nerve pain that are often quoted for lipoic acid used racemic ALA (the 50/50 mixture), not isolated R-ALA, and they are not cited here; our alpha-lipoic acid page covers them. R-ALA is the naturally occurring half of that mixture, but nothing cited on this page shows it helps nerve symptoms.

Antioxidant Activity (Both Water and Lipid Soluble)

Lipoic acid dissolves in both water and fat, and in laboratory work it can help regenerate other antioxidants such as vitamin C, vitamin E and glutathione. In people, the only antioxidant-related measurement in the studies cited here was plasma glutathione in a pilot absorption study of six younger and six older adults. That is one blood marker in a very small single-dose study, not evidence of a health benefit.

Insulin Sensitivity / Blood Sugar

This page cites no trial of blood sugar control. One cited absorption study, in six healthy volunteers, also recorded plasma glucose after a single dose, which is a side measurement rather than a test of blood sugar benefit. Lipoic acid has been studied for glucose control in people with type 2 diabetes, but those studies used racemic ALA and are covered on our alpha-lipoic acid page. Nothing here supports using R-ALA in place of prescribed diabetes treatment.

Mitochondrial Function

Lipoic acid is made in the body and acts as a helper molecule for enzymes that turn food into energy inside cells. That is established biochemistry, but none of the studies cited on this page measured energy, fatigue or exercise capacity in people.

Metal Binding (Laboratory Chemistry Only)

In test-tube chemistry, lipoic acid can bind metals such as mercury, arsenic and cadmium. No study cited on this page measured heavy metals in any person. Chelation for suspected heavy metal poisoning is a medical procedure that requires diagnosis and supervision by a doctor, and unsupervised chelation has caused serious harm. Do not use R-lipoic acid to try to remove metals from your body.

Mechanism of action

1

Endogenous Mitochondrial Cofactor

R-ALA is the naturally-occurring enantiomer in mitochondria — bound to specific lysine residues on enzymes (lipoyllysine). Cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, glycine cleavage system.

2

R-ALA vs S-ALA Activity

R-form is biologically active; S-form has minimal direct biological activity. A racemic (50/50) product therefore delivers about half its milligrams as the R form. Whether that means a stronger effect in people has not been tested in any study cited here; the cited research compared blood levels only, not results.

3

Glutathione Recycling

In laboratory work, lipoic acid converts used-up (oxidized) glutathione back to its active form, which is why it is described as helping the body's own antioxidant system. This is mechanism, not a measured benefit in people.

4

AMPK Activation

In laboratory studies lipoic acid activates an enzyme called AMPK, which is involved in how cells take up and burn fuel. This is a proposed mechanism from cell and animal work, not something measured in the human studies cited on this page.

Clinical trials

1
Blood Levels of Sodium R-Lipoate in 12 Healthy Adults (absorption study)

A pharmacokinetic study (PMID 18069903) giving a single 600 mg dose of sodium R-lipoate and measuring how much appeared in the blood over time (peak level, total exposure, time to peak, half-life).

12 healthy adults.

The stabilized sodium salt reached measurable levels in the blood after a single dose. Key limitation: this study measured blood concentrations only. It did not measure nerve symptoms, blood sugar or any other health outcome, and there was no test of benefit against placebo. The neuropathy trials often quoted for lipoic acid used the racemic form and are not cited on this page.

2
Absorption of an R-Lipoic Acid and Cyclodextrin Complex in 6 Healthy Volunteers

A small bioavailability study (PMID 27314343) comparing an R-lipoic acid and gamma-cyclodextrin complex with plain R-lipoic acid, measuring blood levels of lipoic acid and plasma glucose after dosing.

6 healthy volunteers.

The cyclodextrin complex produced higher blood levels of R-lipoic acid than the plain form. Limitations: only six people, a single-dose absorption design, and no clinical endpoint such as HbA1c or long-term blood sugar control. Plasma glucose was an incidental blood measurement, not evidence that the supplement improves blood sugar.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (nausea, abdominal pain, heartburn).
Hypoglycemia — particularly with insulin/sulfonylureas.
Headache.
Skin rash rare.
Insulin autoimmune syndrome (Hirata's disease) — rare reports of severe hypoglycemia from ALA-induced anti-insulin antibodies; HLA-DRB1*04:06 genetic predisposition (more common in Japanese populations); reversible with ALA discontinuation.
Body odor (sulfur compound).

Important Drug interactions

Insulin / sulfonylureas — additive hypoglycemic effect; monitor blood glucose closely.
Metformin — generally compatible; modest additive.
Thyroid medications — theoretical reduced absorption; separate by 4 hours.
Chemotherapy — theoretical interactions; consult oncologist.
Medications with known mitochondrial toxicity: no cited study tested lipoic acid for this, and it should not be used to try to offset a medication's side effects.
Pre-surgery — discontinue 1-2 weeks before to avoid hypoglycemia during fasting.

Frequently asked questions about R-Lipoic Acid (Natural / Stabilized R-ALA)

What is R-lipoic acid?

R-lipoic acid is one form of alpha-lipoic acid (ALA), and it is the form the body makes itself. Standard ALA supplements are a 50/50 mix of the R and S forms, while R-lipoic acid supplies only the R form, so it is sold at lower doses. Almost all of the human outcome research has used the mixed form, so see our alpha-lipoic acid page for what the trials actually found.

Is R-lipoic acid better than regular alpha-lipoic acid?

No study cited here shows that it works better. The human comparisons that exist measured blood levels only, and stabilized R-lipoic acid does reach higher blood levels than the plain, unstabilized form. Better absorption is not the same as a better result. Nearly all of the outcome research on lipoic acid used the cheaper mixed form, and R-lipoic acid is less stable and more expensive.

How much R-lipoic acid should I take?

Products usually supply 100 to 300 mg per day, lower than typical mixed ALA doses. That range comes from product labels, not from the studies cited here, which gave single doses to measure absorption and never established an effective daily amount. Stabilized forms keep better on the shelf. Talk to your doctor before starting, especially if you take diabetes medication.

Is R-lipoic acid safe?

It is generally well tolerated; mild stomach upset can occur. Because it may lower blood sugar, people on diabetes medication should monitor levels and check with their doctor, as with any lipoic acid.

What is R-Lipoic Acid used for?

R-Lipoic Acid is researched primarily for Metabolic Health and Antioxidant. None of the four studies cited on this page looked at nerve symptoms or any other health outcome. They measured blood levels only.

What is the recommended dosage of R-Lipoic Acid?

The clinically studied dose is Products typically supply 100-300 mg/day of R-ALA. The cited studies gave only single absorption doses (600 mg sodium R-lipoate; 50 to 600 mg racemic thioctic acid), not a daily regimen. Always follow the product label and check with a healthcare provider for personal advice.

Is R-Lipoic Acid safe, and does it have side effects?

For most healthy adults, R-Lipoic Acid is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress (nausea, abdominal pain, heartburn). It may also interact with some medications. R-Lipoic Acid is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does R-Lipoic Acid interact with any medications?

Possible interactions include: Insulin / sulfonylureas — additive hypoglycemic effect; monitor blood glucose closely. Metformin — generally compatible; modest additive. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for R-Lipoic Acid?

NutraSmarts rates the evidence for R-Lipoic Acid as Preliminary (1 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects Altern Med Rev. 2007;12(4):343-51.PubMedUsed to support: A pharmacokinetic study in 12 healthy adults given a single 600 mg dose of sodium R-lipoate, reporting peak blood level, total exposure, time to peak and half-life. Honesty: this is an absorption study only. It shows that the stabilized salt gets into the blood, not that it produces any clinical benefit or any advantage over racemic ALA.
  2. Ikuta N, Okamoto H, Furune T, Uekaji Y, Terao K, Uchida R, Iwamoto K, Miyajima A Bioavailability of an R-alpha-Lipoic Acid/gamma-Cyclodextrin Complex in Healthy Volunteers Int J Mol Sci. 2016;17(6):949. doi: 10.3390/ijms17060949.PubMedUsed to support: Backs the absorption claim only: in six healthy volunteers, complexing R-ALA with gamma-cyclodextrin raised its blood levels, which reflects that plain R-ALA is unstable. Honesty: a formulation/PK study; it addresses absorption, not proof of clinical superiority of R-ALA.
  3. Keith DJ, Butler JA, Bemer B, Dixon B, Johnson S, Garrard M, Sudakin DL, Christensen JM Age and gender dependent bioavailability of R- and R,S-alpha-lipoic acid: a pilot study Pharmacol Res. 2012;66(3):199-206. doi: 10.1016/j.phrs.2012.05.002.PubMedUsed to support: Backs the bioavailability claim: directly compared sodium-R-ALA, unstabilized R-ALA and racemic R,S-ALA absorption across age/sex. Honesty: a pilot study in six younger and six older adults that measured plasma lipoic acid and plasma glutathione only. The neuropathy and blood sugar evidence usually quoted for lipoic acid comes from racemic alpha-lipoic acid, not from isolated R-ALA.
  4. Breithaupt-Grogler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data Eur J Pharm Sci. 1999;8(1):57-65. doi: 10.1016/s0928-0987(98)00061-x.PubMedUsed to support: Cited for the 'R form is better absorbed' premise: this study gave oral racemic thioctic acid (the 50/50 mixture, not R-lipoic acid) at doses from 50 to 600 mg and measured blood levels of each form separately. Honesty: this is enantioselective pharmacokinetics, supporting an absorption rationale only - it does not show R-ALA is clinically superior to racemic ALA.